US$ 20.98
glp-1 data Receptor Agonist Market Size GLP-1 Antagonists Increase Plan Drug
Description
Moulton CD, Hopkins CWP, Ismail K, Stahl D

Results go directly to the Asymmetric Health team for analysis, typically within a few business days

Wadden TA, Hollander P, Klein S, Niswender K, Woo V, Hale PM et al (2013) Weight maintenance and additional weight loss with liraglutide after low-calorie-diet-induced weight loss: the SCALE Maintenance randomized study

First, we leveraged the All of Us Research Program, a large, diverse, dataset with longitudinal electronic health record data, improving the robustness of the findings to real-world clinical populations with diabetes and/or obesity

SGLT-2 inhibitors and GLP-1 receptor agonists in metabolic dysfunction-associated fatty liver disease

(Fast Company) The U.S